Edgewise Therapeutics, Inc.
EWTX
Kedudukan dalam Saham
#3979
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing... Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
Harga Saham
$38.12
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$4.10B
Perubahan (1 hari)
2.50%
Perubahan (1 tahun)
147.69%
Negara
US
Perdagangan Edgewise Therapeutics, Inc. (EWTX)
Kategori
Healthcare
Sejarah pecahan saham untuk Edgewise Therapeutics, Inc. (EWTX)
Saham Edgewise Therapeutics, Inc. (simbol: EWTX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham EWTX yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham EWTX.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham EWTX yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham EWTX.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
